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A qualitative study on pharmacy policies
toward over‑the‑counter syringe sales in a rural
epicenter of US drug‑related epidemics
Monica Fadanelli1* , Hannah L. F. Cooper1, Patricia R. Freeman3, April M. Ballard1, Umed Ibragimov1 and
April M. Young2

Abstract
Background: Expanding access to sterile syringes in rural areas is vital, as injection-related epidemics expand beyond
metropolitan areas globally. While pharmacies have potential to be an easily accessible source of sterile syringes,
research in cities has identified moral, legal and ethical barriers that preclude over-the-counter (OTC) sales to people
who inject drugs (PWID). The current study builds on prior urban-based research by elucidating (1) pharmacy OTC
policies and (2) pharmacists’ rationale for, and barriers and facilitators to, OTC syringe sales in a US rural area hard hit by
drug-related epidemics.
Methods: We conducted 14 semi-structured interviews with pharmacists recruited from two Eastern Kentucky
health districts. Interview domains included experiences with, and attitudes toward, selling OTC syringes to PWID.
Constructivist grounded theory methods were used to analyze verbatim transcripts.
Results: Most pharmacists operated “restrictive OTC” pharmacies (n = 8), where patients were required to have a
prescription or proof of medical need to purchase a syringe. The remainder (n = 6) operated “open OTC” pharmacies, which allowed OTC syringe sales to most patients. Both groups believed their pharmacy policies protected
their community and pharmacy from further drug-related harm, but diverging policies emerged because of stigma
toward PWID, perceptions of Kentucky law, and belief OTC syringe sales were harmful rather than protective to the
community.
Conclusion: Our results suggest that restrictive OTC pharmacy policies are rooted in stigmatizing views of PWID.
Anti-stigma education about substance use disorder (SUD), human immunodeficiency virus (HIV), and Hepatitis C
(HCV) is likely needed to truly shift restrictive pharmacy policy.
Keywords: People who inject drugs, Rural, Syringe sale, Pharmacy, Attitudes, HIV, HCV, Risk environment framework,
Qualitative
Introduction
Expanding access to sterile syringes in rural areas is
vital as epidemics of injection-related human immunodeficiency virus (HIV) and hepatitis C (HCV) escalate
*Correspondence: fadmonic@gmail.com
1
Emory University Rollins School of Public Health, 1518 Clifton Rd,
Atlanta, GA 30322, USA
Full list of author information is available at the end of the article

outside metropolitan areas in the USA (US), Canada,
China, and elsewhere [34, 45, 49]. Testifying to this
expansion in the USA, the fastest-moving HIV outbreak
ever identified in the USA was detected among people who inject drugs (PWID) in rural Indiana in 2015
[10], and a 2016 assessment conducted in response to
this outbreak concluded that the counties at greatest
risk for injection-related HIV and HCV outbreaks were
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“overwhelmingly” rural [45]. Subsequent epidemiologic
data support this assessment. In the USA, two primarily
rural states—Kentucky and West Virginia—were among
the highest rates of reported acute HCV cases in 2018,
about triple the national average rate of 1.2, at 3.7 and 3.8
per 100,000 persons, respectively [5].
Pharmacies may be valuable sources of sterile syringes
in rural areas hard hit by injection-related epidemics. In
many rural areas globally, pharmacies are plentiful, and
pharmacists are one of the most accessible frontline
health care providers; they are well positioned to provide
care and advice, especially for vulnerable populations in
limited resource settings [14, 21, 43]. In the USA, data
indicate that 89% of Americans live within five miles of
a pharmacy [2, 37]. In the USA, nationally, 20% of SSPs
reported their primary location as rural, compared to
69% reported their primary location as urban and 9%
reported their primary location as suburban [17, 18]. In
rural areas that already have syringe service programs
(SSPs), pharmacies may be vital complements to these
existing programs: while SSPs may have limited operating hours, rural pharmacies may be open for upward of
eight hours a day, five days a week [4]. These hours may
enhance access to sterile syringes among rural PWID
who work or have other time constraints that impact
attendance, fear attending an SSP [22, 44], or due to local
SSP closures [28, 29].
Research conducted in cities, however, has identified barriers to over-the-counter (OTC, i.e., without a
prescription) pharmacy sales of syringes to PWID. In
many countries, criminalization of possession and use
of drugs and paraphernalia [16] or ambiguous or incongruent laws regulating syringe sales create apprehension
among some pharmacists, curtailing OTC syringe sales
[8, 9, 21]. While access to, and support for, OTC syringes
has increased the USA in response to the HIV epidemic
and opioid epidemic [24, 47], the USA still lags behind
countries like the United Kingdom, France and Canada
regarding decriminalizing syringe possession and OTC
syringe sales [41]. Additionally, commercial and moral
concerns among pharmacists can help fuel prohibitive or restrictive pharmacy-level OTC syringe policies;
some pharmacists operating in urban areas express concern that their business may be disrupted by PWID, and/
or worry about possible moral consequences of selling
OTC syringes to people who will use them for illegal and
possibly life-threatening behaviors [8, 9, 48]. As a result,
research conducted in cities indicates that pharmacists
act as gatekeepers [8, 9] and often establish their own
prohibitive or restrictive policies, even when practicing
in a jurisdiction that permits OTC syringe sales.
Few studies have explored this topic in rural areas.
Most qualitative research on OTC syringe sales in rural
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areas has focused on PWID experiences with purchasing OTC syringes in pharmacies [22, 33] and hints at
considerable pharmacy-based barriers to OTC sales. A
landmark 2021 quantitative study conducted in three
predominately rural US Appalachian states revealed significant differences in pharmacists’ behaviors and perceptions across state lines, suggesting that the political
environment fosters some but not all pharmacist engagement in OTC syringe sales [20].
Here, we extend this past research to include community pharmacists practicing in two health districts in
Appalachian Kentucky, a region at the heart of the US’
expanding rural opioid epidemic [45]. Interviewed pharmacists practiced in an ambiguous legal environment for
OTC syringe sales at the time of data collection: state law
permitted adult residents to purchase syringes OTC, but
also required pharmacists to maintain a detailed OTC
syringe sale log (Box 1). Pharmacists who did not follow
these procedures could be charged, jailed or fined [25–
27]; dispensing syringes outside an SSP (e.g., through
a pharmacy) was not clearly legal (Box 1) [27]. Within
this ambiguous legal rural context, the present study
is designed to: (1) elucidate OTC syringe sale policies
among pharmacists practicing in two rural health districts; (2) explore pharmacists’ rationales for their OTC
syringe sale policies; and 3) understand pharmacists’ attitudes toward, and other barriers and facilitators, to OTC
syringe sales.

Methods
Sample

The study area captured pharmacists practicing in two
Eastern Kentucky health districts, which collectively
span 12 counties. The current study is embedded within
the broader CARE2HOPE project, a study of the risk
environment for opioid use disorder [12], HIV, HCV,
and overdose in two Eastern Kentucky health districts.
We applied purposive sampling methods to recruit local
pharmacists, seeking to recruit at least one communitybased (i.e., non-hospital based) pharmacy in each county,
and we sought representation from both independent
and chain pharmacies. Research staff contact the pharmacists at these pharmacies via phone or in person and
invited them to learn more about the study and consider
taking part in the consent process and interviews.
Data collection

After pharmacists consented, trained interviewers conducted one-on-one, semi-structured interviews in a private location inside each pharmacy. Each interview lasted
one hour on average, and data were collected between
February 2018–January 2019. The interview guide covered multiple domains, including experiences with, and
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Box 1 Excerpts of Kentucky revised statutes (KRS) from Kentucky law. The state of Kentucky has policies in place governing the sale
and distribution of hypodermic syringes and definitions of what constitutes paraphernalia. Included are the current versions of each
statue as well as the consequences for being charged and found guilty of violating these laws
KRS 217.177 Sale and disposal of hypodermic syringes or needles

KRS 218A.500 Definitions for KRS 218A.500 and 218A.510

(1) No person engaged in sales at retail shall display hypodermic syringes...
in any portion of the place of business which is open or accessible to the
public.
(2) Every person engaged in sales of hypodermic syringes or needles at
retail shall maintain a bound record in which shall be kept:
(a) The name of the purchaser; and (b) The address of the purchaser; and
(c) The quantity of syringes or needles purchased; and (d) The date of the
sale; and (e) Planned use of such syringes or needles
(3) Said record shall be maintained for a period of two years from the date
of the sale and shall be available for inspection during business hours by
any law enforcement officer, agent or employee of the Cabinet for Health
and Family Services or Board of Pharmacy engaged in the enforcement of
KRS Chapter 218A
(4) No person shall present false identification… in obtaining or attempting to obtain any hypodermic syringe or needle
(5) No person engaged in the retail sale of hypodermic syringes or needles
shall:
(a) Fail to keep the records required by this section…

(1) “Drug paraphernalia” means all equipment… which are used, intended
for use, or designed for use in …injecting…or otherwise introducing into
the human body a controlled substance in violation of this chapter. It
includes but is not limited to: …(k) Hypodermic syringes, needles…
(3) It is unlawful for any person to deliver, possess with intent to deliver…
drug paraphernalia, knowing, or under circumstances where one reasonably should know, that it will be used to… inject…or otherwise introduce
into the human body a controlled substance in violation of this chapter…
(5) (a) This section shall not prohibit a local health department from
operating a substance abuse treatment outreach program which allows
participants to exchange hypodermic needles and syringes…
(c) Items exchanged at the program shall not be deemed drug paraphernalia under this section while located at the program
…(7) Any person who violates any provision of this section shall be guilty
of a Class A misdemeanor

KRS 534.040 Fines for misdemeanors and violations

KRS 532.090 Sentence of imprisonment for misdemeanor

(1)…(a) For a Class A misdemeanor, five hundred dollars ($500) …

(1) For a Class A misdemeanor, the term shall not exceed twelve months…
(2)…

attitudes toward, selling OTC syringes to PWID; insights
into the local opioid epidemic and its drivers; and receptivity to pharmacy-based harm reduction initiatives.
Pharmacists received a modest incentive ($10). Interviews were audiotaped and transcribed verbatim.
Analysis

Constructivist grounded theory methods were used to
analyze the transcripts [6, 7]. These methods recognize
that individuals enter the field and analyze data with
pre-existing assumptions and theories, which can act as
“sensitizing constructs.” Charmaz ([6], p. 515) defined
sensitizing constructs as ways of, “…seeing, organizing, and understanding experience.” The analysis was
informed by two sensitizing constructs: (1) past literature on barriers and facilitators of OTC syringe sales like
pharmacist stigma toward PWID, education, and the
political environment and (2) environment types and
levels of influence as defined by the Risk Environment
Framework (REF). REF conceptualizes the risk environment as the “the space where a variety of factors interact
to increase or decrease the chance of harm occurring”
([39], p. 193). REF envisions four environment types,
the social, political, economic, and physical environments, each of which operate across micro- (immediate),
meso- (institutional) and macro- (societal) levels [38, 40].
These different environment types and levels of influence
interact with one another in dynamic ways to produce or

reduce drug-related risks and outcomes [40]. Subsequent
iterations of REF have added two additional environment
types: the health care and law enforcement intervention
environment and the epidemiologic environment [11,
13]. We situated our grounded theory categories within
the context of the Risk Environment Framework (REF).
Therefore, we classified our outcome, pharmacy OTC
syringe sales, as a meso-level characteristic of the local
health care/criminal justice intervention environment.
We followed traditional grounded theory steps. During open coding, two researchers, MF and HC, used
line-by-line coding to develop the codebook. Coupled
with sensitizing constructs, this method allowed themes
or patterns in the data to arise organically rather than
imposing a preconceived coding scheme. We used analytic memos and team discussions, to group codes into
categories like “Protect the community,” and “Political
environment for OTC syringe sales” and sub-categories
like “Beloved community” that were internally coherent and mutually exclusive (Fig. 1). In the next stage, we
used axial coding and the constant comparative method
to explore relationships among categories and sub-categories. Finally, the selective coding stage identified the
core category, “Mitigating drug-related harms or consequences to the community through meso-level pharmacy
policy on OTC syringe sales,” and theoretical sampling
was pursued to fully understand how this core category
related to the others. Negative cases were sought to
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Fig. 1 Visual overview of analytic categories, sub-categories and higher-order codes. The main categories and core category that arose from
the grounded theory analysis are in bold text; sub-categories further describing and explaining the categories are in italic text; and finally, the
higher-order codes, describing most salient concepts, are below the sub-categories in plain text

enhance validity. Transcripts were coded in NVivo 11.
Disagreements were resolved through team discussions,
until a consensus was reached on codes and categories.
One pharmacist operated two pharmacies in two different counties. OTC syringe sale policies differed across
these two pharmacies, in part because county-level policies governing OTC syringe sales varied. We analyzed
data on these two pharmacies separately.
Ethics

Emory University’s Institutional Review Board approved
all data collection protocols for this study. Participants
underwent a consent process prior to interviews.

Results
Our analysis identified two groups of pharmacies, those
that had restrictive OTC policies (“restrictive OTC pharmacies”) and those that did not (“open OTC pharmacies”)
(Fig. 1). The analysis suggested that the following categories intersected within one another to influence whether
pharmacists developed restrictive or open OTC syringe

sale policies: “Protection of the community,” “Political
environment for OTC syringe sales,” “Collective community trauma.” The core category that arose from our analysis was, “Mitigating drug-related harms or consequences
to the community through meso-level pharmacy political
on OTC syringe sales,” which intersected all other categories. Below we situate our categories from our grounded
theory within the Risk Environment Framework, communicating our findings using REF domains.
Overview and sample characteristics

Saturation was achieved with a sample of 14 pharmacists who operated 15 pharmacies, among which nine of
twelve counties were represented. The sample was 2/3rds
male, and all pharmacists identified as non-Hispanic
White. The pharmacists in our sample represented 23%
of all independent retail (i.e., non-hospital based) pharmacies located in the two health districts. Only one pharmacist worked in a retail pharmacy chain; other chain
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pharmacists either reported they had no time for an
interview or were forbidden from participating.
Pharmacy policy toward over‑the‑counter syringe sales

The analysis revealed two groups of pharmacies (Fig. 1):
“restrictive OTC” pharmacies (n = 8) and “open OTC”
pharmacies (n = 6). Pharmacies with restrictive policies
required that patients provide proof of “legitimate medical need” before selling syringes OTC. Three of the eight
restrictive pharmacies required that patients have a prescription for an injectable medicine and that they access
that medication at the same pharmacy:
[I only allow people to purchase a syringe OTC] if
they get insulin here. I don’t just sell needles over the
counter.
Charlie*1
The other five “restrictive” pharmacies had policies that
permitted some leniency if an unfamiliar patient could
“reasonably convince” the pharmacist that they had
a “legitimate medical need” for a syringe, which only
included the injection of licit medications like insulin,
B12, or testosterone:
…If you can tell me the type of insulin you take and
[that] it’s something that you need to inject; yes, you
can have some [OTC] syringes.
Chris
To assess “legitimacy,” restrictive pharmacies established
protocols to vet unfamiliar patients. These protocols varied slightly but included one or more of the following: (1)
asking the patient why they required syringes; (2) calling
the patients’ home pharmacy to verify that they had a
prescription for an injectable medication; and/or (3) asking the patient about their medication.
We have a process if need be. We occasionally [sell
OTC syringes] to people if they are in need…We try
to make sure that they have enough of a background
info… usually at that point, if they can’t answer
those questions pertaining to the medicine, then we
know what’s going on.
Alex
In contrast, six pharmacies developed “open OTC sales”
policies, in which they sold OTC syringes to almost any
patient, as long as staff believed patients complied with
Kentucky regulations,
As a general rule, [we’re] more than happy to sell
syringes over the counter. You do legally have to
provide a government-issued photo ID, and you do
1

*Pseudonyms used to protect participants confidentiality.

Fig. 2 Visual overview of grounded theory integrated with risk
environment framework (REF). We integrated our grounded theory
with the Risk Environment Framework (REF); at the highest level, is
the state-level political environment which influences and shapes
the meso-level local community environment. Finally, the individual
level pharmacist environment influences the meso-level health care/
criminal justice intervention environment (outcome), while the other
environments identified in the meso-level influence and shape the
micro-level individual pharmacist environment

legally have to sign a syringe log that we keep behind
the counter.
Jordan
In one case, an OTC pharmacist developed a policy that
limited OTC syringes sales to patients who resided in the
county where the pharmacy operated, as indicated on
their ID,
...I do require that they live in the county. I don’t
sell [OTC syringes] to people from out of town. They
write their name, address, [and] show their ID. They
put the reason for the purchase and how many
they’re buying.
Cameron
Our analysis indicates that these divergent OTC sales
policies were formed through, and influenced by intersecting features of the macro-, meso-, and micro-level
risk environments, summarized in Fig. 2, and explained
in detail in the following sections.
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Impact of the opioid epidemic on the local community:
collective community trauma

All pharmacies developed their OTC syringe sale policies to mitigate drug-related harms or consequences to
their community, which was identified as the analysis’
core category, (Fig. 1). Close and long-standing social
ties to their Eastern Kentucky communities were highly
salient features of the meso-level social environment
where pharmacists lived and practiced. These features
and pharmacists’ connection to the area were captured
by our sub-category, “beloved community” (Fig. 1). The
majority of the pharmacists were born and raised in the
area and reported familial roots dating back at least one
generation,
[My family has been in this area] forever... My
grandmother was from this area… So my whole family, generally, is just anchored to this area.
Dorian
Most pharmacists described the communities they
served as “tight-knit,” “small town” places, where “everybody knows everybody” and where the people are, “good”
and “trustworthy”:
I feel like it’s a very tight-knit community…It’s got
a hometown feel…The people here of course are
the greatest strength. People here are just different.
They’re just kinder and more willing to lend a helping hand…
Carey
Drug-related crises were features of the meso-level epidemiologic environment that scared and frustrated
pharmacists by eroding their families and their broader
communities. Though the interview guide did not query
personal experiences with drugs, six pharmacists volunteered that they had friends and family members
who struggled with substance use or died as a result of
overdose,
…We do have a drug problem [that’s] increased over
time…You don’t realize it until you try to step outside and look at just how bad it is…my children have
lost friends to the drug problem. I’ve lost friends to
the drug problem. I think it’s a deep problem.
Morgan
All pharmacists voiced multiple negative, far-reaching
impacts of local drug-related epidemics, even if they did
not discuss direct personal experiences.:
...[The opioid epidemic] affects everybody. People get
so far gone, and…All they think about is how to get
it. You can get robbed, your stuff stolen. It affects not
just you, their family, their children. It affects eve-
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rybody that they’re around and people that kind of
aren’t even around them.
Dylan
Our analysis suggests that theses consequences interacted with pharmacists’ shared connection to the communities they served (beloved community), generating
divergent OTC syringe sale policies, with divergences
seemingly shaped by varied perceptions of the epidemiologic, social, and political environments (see Fig. 2). The
following sections describe rationales for restrictive and
open OTC syringe sale policies.
Rationale for restrictive OTC syringe sale policies

Most pharmacists with restrictive policies wrestled with
several barriers to OTC sales including (1) fear that OTC
sales would harm their community or pharmacy; (2)
stigma toward substance use disorder (SUD) and PWID,
and (3) the need to strictly comply with their perception
of Kentucky law. Though many ‘restrictive’ pharmacists
wrestled with what the “right” decision was, they viewed
themselves as gatekeepers and ultimately concluded that
the potential harms to their community and pharmacy
of selling OTC syringes outweighed the benefits of OTC
sales.
Most pharmacists with “restrictive policies” were aware
that sterile syringes reduced transmission of blood-borne
infections, like HIV and Hepatitis C (HCV),
I think [sterile syringe access] would be an advantage for most patients because not sharing needles is
going to decrease the spread of diseases like hepatitis.... [Hepatitis is preventable and Hepatitis infections are] very costly for the medical system...
Chris
However, they were concerned that selling syringes OTC
would further harm their community and pharmacy by
contributing to syringe littering in public spaces, “enabling” or “condoning” drug use, or disrupting their retail
business and/or other customers,
The foot traffic [by PWID] is the worst thing about
[selling syringes to PWID]... It’s just a group of people
[you don’t want constantly on your premises]….we’ve
got some of these elderly people that don’t need to be
[exposed to PWID who act like heathens]…
Jesse
As illustrated by the previous quote, many of the
concerns and rationale expressed by these pharmacists
reflected fearful and stigmatizing views of SUD and
PWID, a feature of the meso-level social environment.
They often used stigmatizing language like “junkie,”
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“dirty” and “bad for business” to describe PWID.
Some viewed PWID as “untrustworthy” and believed
that they would discard their syringes inappropriately
in public spaces, contributing to syringe littering, an
intersecting feature of the epidemiologic and physical
environment; or be disruptive to their other customers, an intersecting feature of the social and economic
environment.
…[PWID] are going to use [the syringe] and then
throw it down in the streets [or] in a park where
the kids are going to go. Nobody wants that…
You’re trusting a population who’s pretty much
[not] trustworthy…I don’t know if [selling syringe
to PWID] is good or bad for the community…only
time will tell.
Dorian
The pharmacists’ rationale for their restrictive policies
was further reinforced by an unclear state macro-level
political environment that placed pharmacists in a difficult “grey area.” Kentucky law mandated that they had
to maintain a log of all OTC sales that contained patient
information including name, address and intended use
for the purchased syringe. For restrictive pharmacists,
sufficiently complying with the law meant ensuring that
patients had “a legitimate medical use” for their syringes,
which did not include injecting illicit substances like
heroin,
Our logbook [requires] the patient say what they’re
using [the syringe] for and it’s one of those things that
I just can’t write something like “heroin” on the line,
you know?
Chris
Some were concerned about the implications of frequent
OTC sales:
I just don’t like someone’s name being on that syringe
log a lot, especially when the Board of Pharmacy has
to come in and look at it, like we’re haphazardly giving them out all the time. That’s really my barrier of
what we have here.
Jesse
Pharmacists with restrictive OTC syringe sale policies assigned different weights to these various concerns, but ultimately viewed themselves as gatekeepers,
protecting their community and pharmacy from escalating drug-related harms, seen as (1) syringe littering,
(2) “enabling” or “condoning” drug use or (3) disrupting
their retail business and/or other customers by attracting PWID to their pharmacies. Their rationale was
further reinforced by their belief that restrictive policies were necessary to legally comply with Kentucky’s
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macro-level political environment (KRS 217.177 and
KRS 218A.500).
Rationale for open OTC syringe sale policies

Pharmacists with open OTC policies shared restrictive
pharmacists’ concern for their community and pharmacy but had a more compassionate perspective; open
OTC pharmacies believed that selling OTC syringes
protected PWID and the broader community from
harm. Their perspective was rooted in the belief that
limiting syringes would not deter PWID from injecting drugs, and that access to sterile syringes decreased
blood-borne infections:
[At first I restricted OTC syringe sales but] after a
while, I became uncomfortable…[a PWID] is not
going to not shoot up if they don’t have a clean
syringe. They’re going to use a dirty syringe.
Jordan
They viewed selling syringes OTC to PWID as aligned
with, or extending their health professional role, and
desired to minimize harm to PWID:
I don’t think you can change the world. But if you
give [PWID] clean needles and things you can at
least keep them healthy as you can keep them…
and I think that fits in with trying to keep people
healthy.
Gerry
Compared to pharmacists with restrictive policies, pharmacists with open OTC policies appeared
to be less steeped in local stigma toward PWID, a feature of the meso-level local social environment. They
expressed more patience and compassion for PWID
and voiced a medicalized of view of SUD. Further, they
did not express concern that PWID would disrupt their
business or other customers.
Pharmacists with open OTC syringe sale policies
believed they were protecting their community, including PWID, from escalating drug-related harms, like
HIV and HCV. They did not express the same level of
concern as restrictive pharmacists about syringe littering, “condoning” or “enabling” drug use or PWID
disrupting their business and/or other customers. The
state macro-level political environment was not mentioned as a barrier for pharmacists with open policies,
and they did not mention attempting to “vet” patients
seeking OTC syringes, beyond the requirements legally
outlined in Kentucky law. This suggests OTC pharmacies believed (1) that sufficient compliance with state
law only required asking for ID and completing the
syringe log; and/or (2) they perceived the consequences
for “selling paraphernalia” to be low or minimal, and
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they had a strong motivation to sell syringes OTC
because it was “the right thing to do.”
Negative case

We identified a negative case that did not align with our
grounded theory: one pharmacist (Terry) reported that
they could not sell syringes OTC because a local ordinance was in place that required all patients to have a
prescription to purchase sterile syringes. This rule conflicted with their personal beliefs about OTC syringe
sales: if it were not for the county law, they would sell
syringes OTC:
“I would [sell syringes OTC] but [there’s a county
law in place] that says patients have to have a prescription [for syringes]…”
Terry

Discussion
Our qualitative analysis of pharmacists in two Eastern
Kentucky health districts, an epicenter of the US opioid
epidemic, found diverging OTC syringe sale policies,
which we conceptualize as a feature of the meso-level
health care/criminal justice intervention risk environment. Eight pharmacists had restrictive OTC syringe policies, requiring that patients provide proof of “legitimate
medical need” to purchase an OTC syringe. Six pharmacists had open OTC syringe policies, which allowed most
patients to purchase syringes OTC, provided the patient
showed ID and supplied the information required
to complete the syringe log.
Our study is the first qualitative study, to our knowledge, to examine pharmacist attitudes toward OTC
syringe sales in a rural context in the USA. Our results
echo and extend previous qualitative and quantitative
work globally, in US cities and in the Appalachian region
[19, 20, 23, 32, 36]. Similar to the other studies conducted in urban and rural areas globally, and to quantitative studies conducted in the US Appalachian South, we
found that stigma toward SUD and PWID combined with
restrictive laws governing drug paraphernalia and varied
interpretations of these policies by pharmacists, to discourage pharmacy-based OTC syringe sales.
We build on previous studies such as Chiarello [9],
Parry et al. [36] and Hagemeier et al. [20], by exploring the risk environment for OTC syringe sales in rural
pharmacies, and by using qualitative data to enrich our
understanding of the barriers and facilitators of OTC
syringe sales in a rural context. We map our findings onto
the REF (Fig. 2), finding that pharmacists experienced
the opioid epidemic, a feature of the epidemiologic risk
environment, as devastating their tightly knit, beloved
communities, a feature of the meso-level social risk
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environment (Fig. 2). While pharmacists had a shared
experience of community threat or trauma, divergent
OTC syringe policies were rooted in varied perceptions
of which threat they needed to protect their communities from. Pharmacists with restrictive OTC syringe policies were influenced by community stigma and believed
that substance use and syringe littering were the primary
threats to their community. To overcome these threats,
they restricted PWID OTC syringe access. Conversely,
pharmacists with open OTC sale policies perceived
injection-related harms (e.g., HCV, HIV) as the primary
threat and tried to counter it by getting sterile syringes
into PWIDs’ hands. The political risk environment was
also salient and further reinforced both groups’ policies
and rationale; restrictive pharmacists were burdened by
the syringe log, and intent on ensuring each patient had
a “legitimate medical need,” aligned with KRS 217.177
and KRS 218A.500 (Fig. 2). Conversely, open OTC pharmacists did not perceive the pharmacy log as a barrier,
suggesting that they believed that sufficient compliance
with state law only required requesting ID and completing the syringe log, or that they perceived the benefits of
doing the “right thing” outweighed the risk of legal consequences for “selling paraphernalia.”
Features of the risk environment identified in the current study that were similar to those found in urban areas
included stigma toward PWID, a feature of the social
environment, and macro- and meso-political related barriers, that caused hesitation among some pharmacies.
However, at the time of our interviews, there were many
features of the social, epidemiologic and the political risk
environment that may be unique to these rural areas.
The social ties in rural areas, a salient feature of the
social environment, have been found to be qualitatively
different compared to metropolitan areas [15, 30, 46].
For example, the Pew Research Center found that 63%
of rural residents surveyed reported living in their communities for eleven or more years, compared to 53% of
suburban residents and 45% of urban residents [35]. One
of our categories, the beloved community, highlights the
involvement of the social risk environment and its centrality in co-producing the risk environment for syringe
access. The pharmacists in our sample had lived in the
area for decades; often their families lived in the area
for generations. In these tight-knit communities, pharmacists frequently knew community members impacted
by drug-related harms. Moreover, the severe and widespread nature of the opioid epidemic was unavoidable
and was frequently described as “impacting everybody
and everything.”
While differences in the strength, connectedness and
structure of social ties in rural areas have been observed
previously [15, 30, 46], we seek to center this feature of
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the social environment. As reflected in the language
of the participants, the opioid epidemic is a shared and
repeated collective trauma [3] that has devastated these
already vulnerable communities [42]. We suggest that the
differences between metropolitan and rural social environments impact the experience and consequences of
collective trauma, creating the unique risk environment
found in our study. Previous literature has noted how
social ties in rural areas are stronger and more multiplex
[1]; the smaller and more interconnected social networks
of rural Appalachian residents compared to metropolitan residents, and generational family history in the area,
mean that pharmacists intimately know community
members suffering with OUD, dying from overdose and
living with other drug-related consequences. We suggest
that this social environment may be different from what
is seen in cities, where social networks are larger, and
individuals are more transient.
Changes in the political environment and future
implications

Effective July 1, 2021, the General Assembly of the
Commonwealth of Kentucky enacted new statutory
language officially relinquishing the syringe log requirement outlined in KRS 217.177 and adding language to
KRS 218A.500 exempting pharmacies from paraphernalia restrictions. Additionally, the amendments to KRS
217.177 require pharmacies that sell syringes OTC to
make available educational materials about safe syringe
disposal, syringe exchange programs, substance use disorder treatment, as well as a verbal, physical or electronic
offer for a naloxone prescription.
Previous studies suggest that evolving political environments may encourage OTC syringes sales among less
enthusiastic pharmacists [9, 20]. By removing the log
requirement for OTC syringe sales, more pharmacists
may engage in OTC syringe sales. Our study suggests,
however, that these macrolevel political changes may not
be sufficient to transform pharmacists’ restrictive policies; while concerns about Kentucky law were salient for
these pharmacists, they also viewed OTC sales as potentially harmful to the community and sought to gatekeep
syringes from PWID. To shift these pharmacists’ OTC
policies, additional anti-stigma education about the
nature of SUD, injecting drug use, HIV, and HCV might
be warranted. Additionally, testimonies from pharmacists engaged in OTC syringe sales might also shift attitudes and fears about the true impact of OTC sales on
their pharmacy practice. Future studies should consider
pre- and post-comparisons of pharmacy OTC sales, attitudes and practices among pharmacists in states where
laws have changed.
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Limitations and strengths

We used Maxwell’s framework to consider the study’s
validity [31]. Descriptive validity (i.e., the extent to which
we captured what was said) was strengthened by using
verbatim transcripts and comparing the transcripts to
audio recordings. Interpretive validity (i.e., the extent to
which the researcher captured participants’ meanings)
was enhanced through extensive reflection, team discussions, and descriptive memoing. Theoretical validity was
enhanced by a search for negative cases.
At the time of their interview, all but one pharmacist in
our study worked at an independent pharmacy. The current study could not capture, and may not be generalizable to, policies and practices in a chain-based pharmacy
setting. A previous study by Goodin et al. [19] in Kentucky found more chain pharmacies sold syringes without a prescription compared to independent pharmacies
(71.5% vs. 51.9%, respectively). Their results suggested
that barriers experienced and perceived by chain and
independent pharmacies may be different and impact
OTC syringe access [19].

Conclusion
Expanding pharmacy-based access to OTC syringes is
vital to curbing HIV and HCV epidemics in rural areas,
in the USA and globally. While all pharmacists we interviewed developed their pharmacies’ OTC syringe policies to protect their beloved communities, more than
half (n = 8) enacted policies that prohibited or greatly
impeded OTC syringe sales. Our results suggest that the
recent changes to Kentucky laws promoting OTC syringe
sales may be insufficient to drastically shift restrictive
policies, given that these organizational policies are also
rooted in stigmatizing views of PWID and SUD. Legal
changes should be accompanied by anti-stigma interventions designed to help currently restrictive pharmacists
view HIV and HCV, rather than PWID themselves, as
principal threats to their communities.
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